These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23050586)

  • 1. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
    Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
    J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers.
    Ying J; Poon FF; Yu J; Geng H; Wong AH; Qiu GH; Goh HK; Rha SY; Tian L; Chan AT; Sung JJ; Tao Q
    Br J Cancer; 2009 Feb; 100(4):663-9. PubMed ID: 19156137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
    Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
    BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
    Ying J; Li H; Murray P; Gao Z; Chen YW; Wang Y; Lee KY; Chan AT; Ambinder RF; Srivastava G; Tao Q
    Epigenetics; 2007; 2(1):15-21. PubMed ID: 17965626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas.
    Li L; Xu J; Qiu G; Ying J; Du Z; Xiang T; Wong KY; Srivastava G; Zhu XF; Mok TS; Chan AT; Chan FK; Ambinder RF; Tao Q
    Theranostics; 2018; 8(1):61-77. PubMed ID: 29290793
    [No Abstract]   [Full Text] [Related]  

  • 6. Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
    Ying J; Gao Z; Li H; Srivastava G; Murray PG; Goh HK; Lim CY; Wang Y; Marafioti T; Mason DY; Ambinder RF; Chan AT; Tao Q
    Br J Haematol; 2007 Mar; 136(6):829-32. PubMed ID: 17341268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.
    Zhang L; Zhang Q; Li L; Wang Z; Ying J; Fan Y; He Q; Lv T; Han W; Li J; Yang Y; Xu B; Wang L; Liu Q; Sun Y; Guo Y; Tao Q; Jin J
    J Mol Med (Berl); 2015 Jun; 93(6):691-701. PubMed ID: 25648635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of a proapoptotic cell adhesion molecule, the immunoglobulin superfamily member IGSF4, by promoter CpG methylation protects Hodgkin lymphoma cells from apoptosis.
    Murray PG; Fan Y; Davies G; Ying J; Geng H; Ng KM; Li H; Gao Z; Wei W; Bose S; Anderton J; Kapatai G; Reynolds G; Ito A; Marafioti T; Woodman CB; Ambinder R; Tao Q
    Am J Pathol; 2010 Sep; 177(3):1480-90. PubMed ID: 20709797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation.
    Cui Y; Ying Y; van Hasselt A; Ng KM; Yu J; Zhang Q; Jin J; Liu D; Rhim JS; Rha SY; Loyo M; Chan AT; Srivastava G; Tsao GS; Sellar GC; Sung JJ; Sidransky D; Tao Q
    PLoS One; 2008 Aug; 3(8):e2990. PubMed ID: 18714356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage.
    Zhang Q; Ying J; Li J; Fan Y; Poon FF; Ng KM; Tao Q; Jin J
    J Urol; 2010 Aug; 184(2):731-7. PubMed ID: 20639048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional repression of DLEC1 associates with the depth of tumor invasion in oral squamous cell carcinoma.
    Chan WH; Chang KP; Yang SW; Yao TC; Ko TY; Lee YS; Tsai CL; Tsai CN
    Oral Oncol; 2010 Dec; 46(12):874-9. PubMed ID: 20952247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.
    Qiu GH; Salto-Tellez M; Ross JA; Yeo W; Cui Y; Wheelhouse N; Chen GG; Harrison D; Lai P; Tao Q; Hooi SC
    J Hepatol; 2008 Mar; 48(3):433-41. PubMed ID: 18191269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1.
    Guo Y; Shu L; Zhang C; Su ZY; Kong AN
    Biochem Pharmacol; 2015 Mar; 94(2):69-78. PubMed ID: 25640947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DLEC1 is not silenced solely by promoter methylation in head and neck squamous cell carcinoma.
    Seven D; Yavuz E; Kilic E; Baltaci E; Karaman E; Ulutin T; Buyru N
    Gene; 2015 May; 563(1):83-6. PubMed ID: 25746324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.
    Doerr JR; Malone CS; Fike FM; Gordon MS; Soghomonian SV; Thomas RK; Tao Q; Murray PG; Diehl V; Teitell MA; Wall R
    J Mol Biol; 2005 Jul; 350(4):631-40. PubMed ID: 15967459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLCD1 is a functional tumor suppressor inducing G(2)/M arrest and frequently methylated in breast cancer.
    Xiang T; Li L; Fan Y; Jiang Y; Ying Y; Putti TC; Tao Q; Ren G
    Cancer Biol Ther; 2010 Sep; 10(5):520-7. PubMed ID: 20657189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
    Zhang MY; Calin GA; Yuen KS; Jin DY; Chim CS
    Clin Epigenetics; 2020 Oct; 12(1):150. PubMed ID: 33076962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer].
    Song H; Yi J; Zhang Y; Wang R; Chen L
    Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):233-8. PubMed ID: 21426665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.